Innovo Therapeutics
PrivateLast Round
Seed
Dec 1, 2023
Total Funding Raised
$28.84M
Company Overview
Innovo Therapeutics is a biotechnology company that specializes in the discovery and development of novel protein degrader drugs for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovo Therapeutics Comparables
Compare Innovo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 85% | |
| PostEra | 84% | |
| Aigen Sciences | 83% |
Innovo Therapeutics Funding Rounds
Historical fundraising activity
Innovo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiandao Fund | Seed |
| Ming Bioventures | Seed, Angel |
| Huajin Capital | Seed |
| CICC Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2022
$15M round led by Ming Bioventures
Innovo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Innovo Therapeutics's valuation, stock price, and market status.
Is Innovo Therapeutics a public or private company?
Innovo Therapeutics is a private company.
What is the current stock price of Innovo Therapeutics?
Innovo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Innovo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innovo Therapeutics worth (valuation)?
Valuation information for Innovo Therapeutics is not publicly available.
Can I buy Innovo Therapeutics stock?
Innovo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innovo Therapeutics's last funding round?
Innovo Therapeutics's most recent funding round was Seed on December 1, 2023.
Who are the main investors in Innovo Therapeutics?
Key investors in Innovo Therapeutics include Ming Bioventures, Huajin Capital.
Will Innovo Therapeutics IPO soon?
No public IPO plans have been announced for Innovo Therapeutics.
How can I track Innovo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Innovo Therapeutics's shares on secondary markets.